Arguably, healthcare services are inevitably “rationed”. The relevant question is whether they are allocated by the relative medical need of patients, or by some metric of their status, advantage, or resources.
An ICU doctor taking care of 12 critically ill patients will not divide her/his time perfectly equally among the patients. She/he will, inevitably, allocate the finite hours of their day based on patients’ relative medical need - the sickest will tend to take the most time.
Such “rationing” is inevitable, but it is also just. Injustice enters when factors beyond medical need — e.g. patients’ race, insurance status, income, wealth, language — distort the prioritization of time & services.
That’s why examining the relative utilization rates of care of different groups is an important way to examine medical equity, e.g. work pioneered by Odin Anderson, Ronald Andersen and others at U Chicago since the 1960s.
But in the last couple of decades, utilization research more often focused on the problem of regional differences in utilization so as to shed light on the problem of overutilization, while shifting away from the problem of *equity* of use among groups.
Note that I emphasize services — the supply is fundamentally finite insofar as the “person-hours of medical labor available per capita” truly has a fixed and firm upper limit that technology can literally never eliminate.
That’s simply not true of pharmaceuticals — basically all “rationing” (think hepatitis C drugs) stems from the intellectual property rights of drug firms & not an inability to increase supply/manufacturing.
Needless to say, it is a massive problem when supply is massively outstripped by demand ****due to a surge in objective medical need**** — i.e. a terrible COVID-19 outbreak. In this scenario, the capacity to meet overall need *falls*.
However, it's entirely different when the effective demand for care increases ***due to reduction in financial barriers to care***, because in this scenario, there is zero real increase in objective medical need.
Hence, whatever supply inadequacies may or may not exist, overall objective medical need will be better met given that supply than if those financial barriers were kept in place, as need not means becomes more determinant of use.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
You probably heard: "We don't know if COVID-19 vaccination protects against transmission."
It's an odd statement! Presumably what is meant is: "It almost certainly protects against transmission, but we don't know by exactly how much, and we do know it's less than 100%."
You might think, what's the difference? It's a big difference!
Would you say: "condoms don't protect against HIV"
If you actually meant: "condoms do protect against HIV, although they are not 100% effective."
Hopefully not! You'd confuse people.
We already know for sure COVID vaccination is not 100% effective against transmission because it's not 100% effective against symptomatic infection. Insofar as any of this debate is about 100% efficacy in preventing transmission it should end. There's zero uncertainty.
Eric, with all due respect, this paper describes a web-based survey of a sample recruited from online support groups — but more importantly the vast majority of participants had no evidence of prior COVID-19 infection?
15.9% had positive PCR, and 18.2% had positive antibodies. Even if you assume zero overlap (and why would you?), that means that the majority of these participants, whose demographics are opposite those who typically face severe COVID, never seemed to have COVID?
Make no mistake — COVID is the pandemic of a century — a horrifying, unprecedented plague. But the "long covid" narrative needs revision, rapidly.
We should fight for healthcare that is free at point of service. Imposing payments serves two purposes, both harmful.
First, ideologically, it reinforces the notion that healthcare is a commodity.
Second, practically, it distributes the use of services by means, not needs.
Until we understand the fundamental political, economic, and ideological function of cost-sharing, we will never abolish it.
I could cite dozens of studies showing the medical harm that cost-sharing inflicts, but the reality is that this is a philosophical and political question more than an empiric one, one that I will rephrase as crudely as possible:
OK, so I'll now tweet out the articles I wrote this year, and research projects where I took the lead, in case any of it may be of interest to folks.
It feels odd because so much has changed over the course of this year — politically, medically, everything!
In January, we published a study suggesting that people with VA coverage (where drug copays are non-existent or minimal) forego medications because of cost much less often than those w/ other forms of health coverage.
According to the new CBO report, under single-payer, we could cover ~100% of the population, make medical services free at point of use, and expand benefits — without spending a dollar more. And healthcare providers would still do perfectly well.
If you also add, as we should, universal long term care with no out-of-pocket costs, you'd spend about ~$300 billion more a year on healthcare altogether, they estimate — but we'd have a free-at-point-of-use system with comprehensive benefits for all, including long-term care.
I'll have many more thoughts on this analysis soon, but the bottom line is clear.
Any healthcare reform other than single-payer will either have higher costs or skimpier benefits than single-payer.